- Home
- / Lantheus Medical Imaging
Lantheus Medical Imaging
Stock Price
$110.1
2024-10-29
Market Capitalization
$7.6 B
2024-10-29
Revenue
$1.5 B
FY, 2024
Lantheus Medical Imaging Summary
Company Summary
- Overview
- Lantheus is a company that develops, manufactures, and commercializes diagnostic imaging agents. It offers radiopharmaceuticals and precision diagnostic products. The company’s products are used to diagnose coronary artery disease (CAD), congestive heart failure (CHF), stroke, peripheral vascular disease (PVD), and other conditions.
- Type
- Public
- Status
- Active
- Founded
- 1956
- HQ
- Bedford, MA, US | view all locations
- Website
- https://www.lantheus.com
- Cybersecurity rating
- ESG rating
Table of Contents
Key People
Minnie Baylor-Henry, Director
Daniel Niedzwiecki, Chief Administrative Officer, General Counsel & Corporate Secretary
Dorothy Barr, Senior Vice President, Manufacturing and Technical Operations
LocationsView all
4 locations detected
Bedford, MA HQ
United States
201 Burlington Road, South Building
Billerica, MA
United States
331 Treble Cove Road
Montreal, QC
Canada
1111 Boulevard Dr.-Frederik-Philips, Suite 600
Lund, Skåne län
Sweden
Ideon Science Park, Scheelevägen 27
Lantheus Medical Imaging Financials
Summary Financials
- Revenue (Q1, 2025)
- $372.8M
- Gross profit (Q1, 2025)
- $237.7M
- Net income (Q1, 2025)
- $72.9M
- Cash (Q1, 2025)
- $938.5M
- EBIT (Q1, 2025)
- $102.1M
- Enterprise value
- $7.3B